Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,490 across all filing types
Latest filing 2025-10-02 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Share Issue/Capital Change Classification · 90% confidence The document is a monthly regulatory return (FF301) filed with the HKEX detailing movements in authorised share capital, issued shares, and share option exercises for the month. It is not a financial report, earnings release, or management discussion, but specifically a share capital movement notice. This aligns with “Share Issue/Capital Change” (SHA).
2025-10-02 English
2025 Interim Report
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled '2025 INTERIM REPORT' for 3SBio Inc. It contains comprehensive financial statements (Statement of Profit or Loss, Statement of Financial Position, etc.), management discussion and analysis, and corporate information for the six-month period ended 30 June 2025. It is a full interim financial report, not an announcement or a summary. H1 2025
2025-09-30 English
Notification Letter and Request Form to Non-registered Holders - Notice of publication of 2025 Interim Report
Report Publication Announcement Classification · 90% confidence The document is a notification letter to shareholders (“Non-registered Holders”) announcing the publication of the 2025 Interim Report on the company and Stock Exchange websites, with instructions on how to request printed copies. It does not contain the actual interim financial content itself, but simply informs recipients that the report has been published and how to obtain it. Therefore, this is a Report Publication Announcement rather than the report itself.
2025-09-29 English
Letter to Registered Shareholders - Notice of publication of 2025 Interim Report
Report Publication Announcement Classification · 87% confidence The document is a short shareholder notice informing recipients that the Company’s 2025 Interim Report is now available on the Company and exchange websites. It does not contain any financial figures or detailed interim financial statements itself, but merely announces publication and access instructions. Therefore, it is an announcement of report publication, matching the Report Publication Announcement category (RPA).
2025-09-29 English
2025 Interim Report
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled '2025 INTERIM REPORT' for Hongkong Chinese Limited. It contains comprehensive unaudited condensed consolidated financial statements (Profit or Loss, Comprehensive Income, Financial Position, Changes in Equity, and Cash Flows) for the six months ended 30 June 2025, along with detailed notes to the financial statements. This fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-09-29 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Share Issue/Capital Change Classification · 85% confidence The document is a Hong Kong Exchange listing rule monthly return (Form FF301) detailing movements in authorised share capital, issued shares, treasury shares, share options, and new share issuances (subscription by Pfizer, option exercises, etc.). It is not a full annual or quarterly report but a regulatory filing focused on changes in share capital and share issues. The closest category is “Share Issue/Capital Change” (SHA).
2025-09-08 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.